MA-TRANSMIT-SECURITY
Transmit Security , a leading provider of customer identity and access management (CIAM) SaaS solutions, today announced its significant expansion and growth in Europe to address rapidly growing demand for passwordless customer authentication and other solutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220511006152/en/
In January, the company hired Dr. Thore Rabe as the new Vice President and General Manager for Europe, Middle East and Africa (EMEA). Rabe oversees all aspects of Transmit Security’s business in EMEA. Thore has over 20 years leading European divisions at Qumulo, Dell EMC, NetApp, Fujitsu Siemens, and Computer Associates and earned his doctorate in Economic Sciences.
“Our expansion comes at a critical time, not just for us, but for the market here in Europe. With the increase in account takeover fraud , we’re seeing substantial demand for passwordless customer authentication that doesn’t require a specialized app or token,” says Rabe. “The pandemic-fuelled growth in mobile app usage along with the brick-and-mortar return of consumers means businesses need stronger, easy-to-use authentication that works across all of their channels. Our customers know they have to serve their consumers digitally, no matter where they are or what devices they use.”
Consumers around the world report that they prefer better security and smooth customer experience ; businesses are increasingly turning to passwordless authentication as the solution. With the growing demand in Europe, Transmit Security has invested heavily in the region, more than doubling its Europe-based employees and growing by 255% across EMEA, including its corporate headquarters in Tel Aviv.
Transmit Security’s customers in EMEA include HSBC, UBS, Telepass S.p.A., Santander, MetroBank and NN Insurance, and dozens of other regional and global companies. Transmit Security helps its customers in the region address many customer identity challenges, including improving customer experience across their digital channels while strengthening authentication against phishing and other threats. Altogether, the company’s customers in EMEA represent over €330 billion in annual revenues.
Transmit Security is a Platinum Sponsor at the Gartner Identity & Access Management Summit on May 12-13 in London (booth 202). They will be presenting, “Fortify Security and Remove Customer Barriers with Passwordless” on Friday at 2:45pm.
About Transmit Security
Transmit Security is on a mission to revolutionize consumer identity and access management by reimagining customer experience (CX) and eliminating account takeover fraud and similar risks. CX-focused, cybersecurity-conscious businesses rely on Transmit Security to deliver innovative, passwordless digital identity journeys for their consumers across all channels and devices. Transmit Security’s customers are responsible for more than $1.3 trillion in annual commerce and include many of the largest banks, insurers, and retailers, along with many other leading brands.
For more information, please visit www.transmitsecurity.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220511006152/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release
SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release
Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release
Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston
Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press release
A R$490 million investment expands the supply of raw material used in the production of absorbent items Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
